GeneMedicine Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

GeneMedicine General Information

Description

Developer of oncology therapeutic medicines designed to treat intractable cancers. The company's medicines utilize novel and innovative adenoviral vector platforms, which can selectively lyse cancer cells, express numerous combinations of therapeutic transgenes at a high level, induce an antitumor immune response, and deliver systemic treatments based on oncolytic adenovirus against solid tumors, pancreatic cancers, and metastatic lung and liver cancers, enabling healthcare professionals to get innovative treatment methods in the fields of oncolytic virotherapy and gene and cell therapy.

Contact Information

Website
www.gene-medicine.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 707, 7th Floor, FTC Building
  • Fusion Tech Center, Hanyang University, 222, Wangsimni-ro
  • Seoul, Seongdong-gu 04763
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 707, 7th Floor, FTC Building
  • Fusion Tech Center, Hanyang University, 222, Wangsimni-ro
  • Seoul, Seongdong-gu 04763
  • South Korea
+82

GeneMedicine Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneMedicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jan-2024 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series B) 01-Jul-2021 Completed Clinical Trials - Phase 1
3. Later Stage VC (Series A) 01-May-2019 Completed Startup
2. Seed Round 16-Dec-2018 Completed Startup
1. Accelerator/Incubator 01-Dec-2018 Completed Startup
To view GeneMedicine’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

GeneMedicine Patents

  • 93

    Total Documents Applications and Grants

  • Total Patents Families

  • 64

    Granted

  • 24

    Pending

  • Expiring in next 12 mo

GeneMedicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210386806-A1 Anti-tumor composition Pending 10-Jul-2018
AU-2019300911-B2 Anti-tumor composition Active 10-Jul-2018
EP-3822355-A4 Anti-tumor composition Pending 10-Jul-2018
EP-3822355-A1 Anti-tumor composition Pending 10-Jul-2018
CA-3106093-A1 Anti-tumor composition comprising a recombinant adenovirus Pending 10-Jul-2018 A61K35/761
To view GeneMedicine’s complete patent history, request access »

GeneMedicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GeneMedicine Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
J Curve Investment Venture Capital Minority
Bluepoint Partners Venture Capital Minority
Friend Investment Partners (Seoul) Venture Capital Minority
GB Ventures (Korea) Venture Capital Minority
GTO Investment Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

GeneMedicine FAQs

  • When was GeneMedicine founded?

    GeneMedicine was founded in 2008.

  • Where is GeneMedicine headquartered?

    GeneMedicine is headquartered in Seoul, South Korea.

  • What is the size of GeneMedicine?

    GeneMedicine has 34 total employees.

  • What industry is GeneMedicine in?

    GeneMedicine’s primary industry is Drug Discovery.

  • Is GeneMedicine a private or public company?

    GeneMedicine is a Private company.

  • What is GeneMedicine’s current revenue?

    The current revenue for GeneMedicine is .

  • How much funding has GeneMedicine raised over time?

    GeneMedicine has raised $45.3M.

  • Who are GeneMedicine’s investors?

    J Curve Investment, Bluepoint Partners, Friend Investment Partners (Seoul), GB Ventures (Korea), and GTO Investment are 5 of 14 investors who have invested in GeneMedicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »